Bioactive components in milk

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 5, Issue 6, 2002, Pages 653-658

  German, J Bruce ^a,b   Dillard, Cora J ^a   Ward, Robert E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; FOOD ANALYSIS; FOOD COMPOSITION; GENOMICS; HUMAN; INTESTINE FLORA; MILK; NUTRIENT; NUTRITIONAL VALUE; REVIEW; ANIMAL; BREAST MILK; CHEMISTRY; DIGESTIVE SYSTEM; DISEASE MODEL; EVOLUTION; GENETIC SELECTION; IMMUNOLOGY; INFANT; MICROBIOLOGY; MOUSE; NEWBORN; PHYSIOLOGY; TRANSGENIC ANIMAL;

DARWINIA; MAMMALIA;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DIGESTIVE SYSTEM; DISEASE MODELS, ANIMAL; EVOLUTION; HUMANS; INFANT; INFANT, NEWBORN; MICE; MILK; MILK, HUMAN; SELECTION (GENETICS);

EID: 0012948192     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200211000-00007     Document Type: Review

References (36)

1. Van den Driessche M, Veereman-Wauters G. Functional foods in pediatrics. Acta Gastroenterol Belg 2002; 65:45-51.
2. Newburg DS. Bioactive components of human milk: evolution, efficiency, and protection. Adv Exp Med Biol 2001; 501:3-10. Review of milk components that emphasizes a narrow group of components, but from a broad visionary perspective.
3. Pfeuffer M, Schrezenmeir J. Bioactive substances in milk with properties decreasing risk of cardiovascular diseases. Br J Nutr 2000; 84 (Suppl 1):S155-S159.
4. Scholz-Ahrens KE, Schrezenmeir J. Effects of bioactive substances in milk on mineral and trace element metabolism with special reference to casein phosphopeptides. Br J Nutr 2000; 84 (Suppl 1):S147-S153.
5. Groziak SM, Miller GD. Natural bioactive substances in milk and colostrum: effects on the arterial blood pressure system. Br J Nutr 2000; 84 (Suppl 1):S119-S125.
6. Rutherfurd KJ, Gill HS. Peptides affecting coagulation. Br J Nutr 2000; 84 (Suppl 1):S99-S102.
7. Gopal PK, Pramod K, Gill HS. Oligosaccharides and glycoconjugates in bovine milk and colostrum. Br J Nutr 2000; 84 (Suppl 1):S69-S74.
8. Schlimme E, Martin D, Meisel H. Nucleosides and nucleotides: natural bioactive substances in milk and colostrum. Br J Nutr 2000; 84 (Suppl 1):S59-S68.
9. Molkentin J. Occurrence and biochemical characteristics of natural bioactive substances in bovine milk lipids. Br J Nutr 2000; 84 (Suppl 1):S47-S53.
10. Shah NP. Effects of milk-derived bioactives: an overview. Br J Nutr 2000; 84 (Suppl 1):S3-S10.
11. Hamosh M. Bioactive factors in human milk. Pediatr Clin North Am 2001; 48:69-86.
12. Clare DA, Swaisgood HE. Bioactive milk peptides: a prospectus. J Dairy Sci 2000; 83:1187-1195.
13. Donnet-Hughes A, Due N, Serrant P, et al. Bioactive molecules in milk and their role in health and disease: the role of transforming growth factor-beta. Immunol Cell Biol 2000; 78:74-79.
14. Itoh H, Itakura A, Kurauchi O, et al. Hepatocyte growth factor in human breast milk acts as a trophic factor. Horm Metab Res 2002; 34:16-20.
15. Karhumaa P, Leinonen J, Parkkila S, et al. The identification of secreted carbonic anhydrase VI as a constitutive glycoprotein of human and rat milk. Proc Natl Acad Sci USA 2001; 98:11604-11608. An excellent demonstration of the application of multiple technologies to describe the biology of a biologically active component of milk, a virtual 'how-to manual'.
16. Sternhagen LG, Allen JC. Growth rates of a human colon adenocarcinoma cell line are regulated by the milk protein alpha-lactalbumin. Adv Exp Med Biol 2001; 501:115-120.
17. Magi B, Ietta F, Romagnoli R, et al. Presence of macrophage migration inhibitory factor in human milk: evidence in the aqueous phase and milk fat globules. Pediatr Res 2002; 51:619-624. Interesting speculation of a novel targeting delivery mechanism for labile factors in milk, localization to the sub-milkfat globule membrane space.
18. Schmelz EM, Sullards MC, Dillehay DL, Merrill Jr AH. Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice. J Nutr 2000; 130:522-527.
19. Cases S, Smith SJ, Zheng YW, et al. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci USA 1998; 95:13018-13023.
20. Lardizabal KD, Mai JT, Wagner NW, et al. DGAT2 is a new diacylglycerol acyltransferase gene family: purification, cloning, and expression in insect cells of two polypeptides from Mortierella ramanniana with diacylglycerol acyltransferase activity. J Biol Chem 2001; 276:38862-38869.
21. Cases S, Stone SJ, Zhou P, et al. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem 2001; 276:38870-38876. A leading laboratory revealing the pathway to success in gene discovery.
22. Winter A, Kramer W, Werner FAO, et al. Association of a lysine-232/alanine polymorphism in a bovine gene encoding acyl-CoA: diacylglycerol acyltransferase (DGAT1) with variation at a quantitative trait locus for milk fat content. Proc Natl Acad Sci USA 2002; 99:9300-9305. The culmination of years of genetic mapping, molecular biology and biochemistry assigns varying agricultural phenotype to a single amino acid polymorphism.
23. Peterson JA, Scallan CD, Ceriani RL, Hamosh M. Structural and functional aspects of three major glycoproteins of the human milk fat globule membrane. Adv Exp Med Biol 2001; 501:179-187.
24. Satake M, Enjoh M, Nakamura Y, et al. Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem 2002; 66:378-384.
25. Matar C, Valdez JC, Medina M, et al. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J Dairy Res 2001;68:601-609. Excellent use of probiotic strains varying in single genes to establish mechanisms of their biological and physiological effects.
26. Colker CM, Swain M, Lynch L, Gingerich DA. Effects of a milk-based bioactive micronutrient beverage on pain symptoms and activity of adults with osteoarthritis: a double-blind, placebo-controlled clinical evaluation. Nutrition 2002; 18:388-392.
27. Fiorotto ML, Davis TA, Reeds PJ, Burrin DG. Nonnutritive factors in colostrum enhance myofibrillar protein synthesis in the newborn pig. Pediatr Res 2000; 48:511-517.
28. Rauprich AB, Hammon HM, Blum JW. Effects of feeding colostrum and a formula with nutrient contents as colostrum on metabolic and endocrine traits in neonatal calves. Biol Neonate 2000; 78:53-64.
29. Kuhne S, Hammon HM, Bruckmaier RM, et al. Growth performance, metabolic and endocrine traits, and absorptive capacity in neonatal calves fed either colostrum or milk replacer at two levels. J Anim Sci 2000; 78:609-620.
30. l'Abbe MR, Friel JK. Superoxide dismutase and glutathione peroxidase content of human milk from mothers of premature and full-term infants during the first 3 months of lactation. J Pediatr Gastroenterol Nutr 2000; 31:271-274.
31. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr 2002; 21:1463-1513. Highly interesting summary of a nutritional perspective on one of the most pressing public health issues of the day. Compelling review of the mechanisms by which low dietary calcium intakes modify adipocyte metabolism via the active vitamin D metabolite 1,25 (OH)2 vitamin D.
32. Pereira MA, Jacobs Jr DR, Van Horn L, et al. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA 2002; 287:2081-2089. A 'must-read' for the diet and health field.
33. Liepke C, Zucht HD, Forssmann WG, Standker L. Purification of novel peptide antibiotics from human milk. J Chromatogr B Biomed Sci Appl 2001; 752:369-377. Methodologies for separating and characterizing peptides according to biological criteria, in this case antibiotic actions from milk.
34. Duffy LC. Interactions mediating bacterial translocation in the immature intestine. J Nutr 2000; 130 (Suppl 2S):432S-436S.
35. Oddy WH. Breastfeeding protects against illness and infection in infants and children; a review of the evidence. Breastfeed Rev 2001; 9:11-18.
36. Kerr DE, Plaut K, Bramley AJ, et al. Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice. Nat Biotechnol 2001; 19:66-70. Interesting demonstration of proof of principle of protective biotechnology through genetic engineering by expressing a protective bacterial protein in mammary tissue.